Literature DB >> 21217642

Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.

Nick S Laursen1, Kasper R Andersen, Ingke Braren, Edzard Spillner, Lars Sottrup-Jensen, Gregers R Andersen.   

Abstract

Complement acts as a danger-sensing system in the innate immune system, and its activation initiates a strong inflammatory response and cleavage of the proteins C3 and C5 by proteolytic enzymes, the convertases. These contain a non-catalytic substrate contacting subunit (C3b or C4b) in complex with a protease subunit (Bb or C2a). We determined the crystal structures of the C3b homologue cobra venom factor (CVF) in complex with C5, and in complex with C5 and the inhibitor SSL7 at 4.3 Å resolution. The structures reveal a parallel two-point attachment between C5 and CVF, where the presence of SSL7 only slightly affects the C5-CVF interface, explaining the IgA dependence for SSL7-mediated inhibition of C5 cleavage. CVF functions as a relatively rigid binding scaffold inducing a conformational change in C5, which positions its cleavage site in proximity to the serine protease Bb. A general model for substrate recognition by the convertases is presented based on the C5-CVF and C3b-Bb-SCIN structures. Prior knowledge concerning interactions between the endogenous convertases and their substrates is rationalized by this model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217642      PMCID: PMC3034014          DOI: 10.1038/emboj.2010.341

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  The structure of bovine complement component 3 reveals the basis for thioester function.

Authors:  Folmer Fredslund; Lasse Jenner; Lise B Husted; Jens Nyborg; Gregers Rom Andersen; Lars Sottrup-Jensen
Journal:  J Mol Biol       Date:  2006-06-21       Impact factor: 5.469

2.  Structure of C3b reveals conformational changes that underlie complement activity.

Authors:  Bert J C Janssen; Agni Christodoulidou; Andrew McCarthy; John D Lambris; Piet Gros
Journal:  Nature       Date:  2006-10-15       Impact factor: 49.962

3.  Structure of C3b in complex with CRIg gives insights into regulation of complement activation.

Authors:  Christian Wiesmann; Kenneth J Katschke; JianPing Yin; Karim Y Helmy; Micah Steffek; Wayne J Fairbrother; Scott A McCallum; Lizette Embuscado; Laura DeForge; Philip E Hass; Menno van Lookeren Campagne
Journal:  Nature       Date:  2006-10-15       Impact factor: 49.962

4.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

5.  Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition.

Authors:  Bert J C Janssen; Els F Halff; John D Lambris; Piet Gros
Journal:  J Biol Chem       Date:  2007-08-06       Impact factor: 5.157

6.  Structures of complement component C3 provide insights into the function and evolution of immunity.

Authors:  Bert J C Janssen; Eric G Huizinga; Hans C A Raaijmakers; Anja Roos; Mohamed R Daha; Kristina Nilsson-Ekdahl; Bo Nilsson; Piet Gros
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

7.  Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.

Authors:  Russell P Rother; Scott A Rollins; Christopher F Mojcik; Robert A Brodsky; Leonard Bell
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

8.  Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.

Authors:  Nenoo Rawal; Rema Rajagopalan; Veena P Salvi
Journal:  J Biol Chem       Date:  2008-01-18       Impact factor: 5.157

9.  Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.

Authors:  Paul A Ramsland; Natasha Willoughby; Halina M Trist; William Farrugia; P Mark Hogarth; John D Fraser; Bruce D Wines
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

Review 10.  Molecular dynamics: survey of methods for simulating the activity of proteins.

Authors:  Stewart A Adcock; J Andrew McCammon
Journal:  Chem Rev       Date:  2006-05       Impact factor: 60.622

View more
  32 in total

1.  Crystal structure of C5b-6 suggests structural basis for priming assembly of the membrane attack complex.

Authors:  Alexander E Aleshin; Richard G DiScipio; Boguslaw Stec; Robert C Liddington
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

Review 2.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

Review 3.  How novel structures inform understanding of complement function.

Authors:  Elena Goicoechea de Jorge; Hugo Yebenes; Marina Serna; Agustín Tortajada; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  Semin Immunopathol       Date:  2017-08-14       Impact factor: 9.623

Review 4.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

5.  Structural basis for activation of the complement system by component C4 cleavage.

Authors:  Rune T Kidmose; Nick S Laursen; József Dobó; Troels R Kjaer; Sofia Sirotkina; Laure Yatime; Lars Sottrup-Jensen; Steffen Thiel; Péter Gál; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

6.  Cloning, expression, crystallization and preliminary X-ray diffraction studies of staphylococcal superantigen-like protein 1 (SSL1).

Authors:  Debabrata Dutta; Anirudha Dutta; Atanu Bhattacharjee; Amit Basak; Amit Kumar Das
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-15       Impact factor: 1.056

7.  Structural basis for therapeutic inhibition of complement C5.

Authors:  Matthijs M Jore; Steven Johnson; Devon Sheppard; Natalie M Barber; Yang I Li; Miles A Nunn; Hans Elmlund; Susan M Lea
Journal:  Nat Struct Mol Biol       Date:  2016-03-28       Impact factor: 15.369

Review 8.  Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Authors:  Julien Zuber; Fadi Fakhouri; Lubka T Roumenina; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

9.  A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement.

Authors:  Rasmus K Jensen; Rasmus Pihl; Trine A F Gadeberg; Jan K Jensen; Kasper R Andersen; Steffen Thiel; Nick S Laursen; Gregers R Andersen
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

Review 10.  Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.

Authors:  Daniel Ricklin
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.